Clearmind Medicine Inc. (NASDAQ:CMND) Short Interest Down 16.0% in February

Clearmind Medicine Inc. (NASDAQ:CMND) saw a large decrease in short interest in February. As of February 15th, there was short interest totalling 274,600 shares, a decrease of 16.0% from the January 31st total of 326,800 shares. Approximately 9.2% of the company’s shares are short sold. Based on an average daily volume of 955,100 shares, the short-interest ratio is currently 0.3 days.

Institutional Inflows and Outflows

A hedge fund recently bought a new stake in Clearmind Medicine stock. Virtu Financial LLC acquired a new position in shares of Clearmind Medicine Inc. (NASDAQ:CMND) during the 4th quarter, according to its most recent filing with the SEC. The institutional investor acquired 39,479 shares of the company’s stock, valued at approximately $54,000. Virtu Financial LLC owned 0.92% of Clearmind Medicine at the end of the most recent reporting period. Institutional investors and hedge funds own 96.05% of the company’s stock.

Clearmind Medicine Price Performance

NASDAQ:CMND opened at $1.11 on Friday. The firm has a market cap of $4.73 million, a price-to-earnings ratio of -0.59 and a beta of 1.04. The company has a current ratio of 1.72, a quick ratio of 1.72 and a debt-to-equity ratio of 0.01. The company’s 50-day moving average is $1.39 and its two-hundred day moving average is $1.37. Clearmind Medicine has a 12-month low of $0.95 and a 12-month high of $2.30.

Clearmind Medicine (NASDAQ:CMND) last released its earnings results on Wednesday, January 22nd. The company reported ($0.11) earnings per share (EPS) for the quarter.

About Clearmind Medicine

Clearmind Medicine Inc, a clinical pharmaceutical company, develops novel psychedelic medicines to treat under-served health problems in Canada and internationally. It develops treatments for alcohol use disorders, mental health disorder, binge drinking, obesity and metabolic disorder, and eating disorders, as well as depression, binge eating, psychotherapy, and other addiction and binge behaviors.